Cite
HARVARD Citation
Butler, J. et al. (2021). Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial. European heart journal. pp. 1203-1212. [Online].